Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Neutrophil-to-Lymphocyte Ratio at Post-operative Day 3: a Simple Tool to Exclude Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy

NCT04724551 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.

NCT NCT04724551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04724551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Neutrophil-to-Lymphocyte Ratio at Post-operative Day 3: a Simple Tool to Exclude Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy
Lead sponsor
Institut Paoli-Calmettes
Phase
Observational
Overall status
Completed
Start date
June 1, 2012
Completion date
February 28, 2021
Enrollment
648 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas neoplasm